<DOC>
	<DOCNO>NCT01601340</DOCNO>
	<brief_summary>The purpose study evaluate effect HQK-1001 Hb F subject sickle cell disease .</brief_summary>
	<brief_title>Effects HQK-1001 Patients With Sickle Cell Disease</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>Males females 12 60 year age Diagnosis SCD , type Hb SS Hb SB0 Thalassemia At least 1 episode SCD pain crisis , acute chest syndrome , acute SCD complication , leg ulcer 12 month prior screen Not treat Hydroxyurea ( HU ) ; HU treatment previously administer discontinue , least 3 month must elapse since last dose HU If subject transfuse 3 month prior screen , Hb A level &lt; 20 % screen Baseline Hb F level obtain within 14 day prior randomization Able swallow tablet Able willing give inform consent and/or assent If subject woman childbearing potential ( WCBP ) , must negative serum pregnancy test within 14 day first dose HQK1001 negative urine pregnancy test prior dose Day 1 If subject WCBP , must agree use effective form contraception start screen one month HQK1001 discontinuation Sexually active male subject vasectomy must agree use latex condom WCBP partner ensure partner ( ) use effective form contraception start screen one month HQK1001 discontinuation . Assigned regular transfusion program Use erythropoiesis stimulate agent within 90 day prior screen An SCD pain crisis SCDrelated acute complication within 3 week prior randomization More 5 SCD pain crisis SCDrelated acute complication within 12 month prior screen Pulmonary hypertension require therapy ALT AST &gt; 3x ULN Serum creatinine &gt; 1.5x ULN Serum amylase level &gt; 1.5x ULN Serum lipase level &gt; 1.5x ULN A serious , concurrent illness would limit ability complete comply study requirement An acute illness ( e.g. , febrile , GI , respiratory ) within 72 hour prior screen History syncope , clinically significant dysrhythmias resuscitation sudden death due SCDrelated complication Symptomatic peptic ulcer , hiatus hernia , gastroesophageal reflux disease ( GERD ) History pancreatitis Chronic opiate use , , view investigator , could confound evaluation investigational drug Current abuse alcohol drug Use another investigational agent within 4 week 5 halflives , whichever longer , prior screen Currently pregnant breast feeding child Known infection HIV1 Infection hepatitis B hepatitis C , subject currently antiviral therapy place therapy</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>